Haemonetics (HAE) Receivables - Other (2012 - 2018)
Haemonetics (HAE) posted quarterly Receivables - Other of $5.0 million for Q1 2018, up 72.41% year-over-year from $2.9 million in Q1 2017, and little changed quarter-over-quarter from $5.0 million in Q4 2017.
Haemonetics (HAE) Receivables - Other (2012 - 2018) Analysis & Trends
Haemonetics' Receivables - Other history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2018.
- In Q1 2018, Receivables - Other rose 72.41% year-over-year to $5.0 million; the TTM figure through Mar 2018 stood at $5.0 million (up 72.41% YoY), while the FY2018 annual figure was $5.0 million, up 72.41% from the prior year.
- Receivables - Other for Q1 2018 stood at $5.0 million, roughly flat from $5.0 million in the prior quarter.
- The five-year high for Receivables - Other was $5.0 million in Q4 2017, with the low at $2.1 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 5.00 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 30, 2017 | 5.00 Mn |
| Dec 30, 2017 | 5.00 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Jul 1, 2017 | 2.90 Mn |
| Jul 1, 2017 | 2.90 Mn |
| Apr 1, 2017 | 2.90 Mn |
| Apr 1, 2017 | 2.90 Mn |
| Dec 29, 2012 | 8.20 Mn |
| Dec 29, 2012 | 8.20 Mn |
| Sep 29, 2012 | 100,000.00 |
| Sep 29, 2012 | 100,000.00 |
| Mar 31, 2012 | 3.20 Mn |
| Mar 31, 2012 | 3.20 Mn |